Eli Lilly and Company

Science has been our calling from the beginning. Colonel Eli Lilly founded the company in 1876 and charged employees to “take what you find here and make it better and better.” More than 147 years later, we remain committed to his vision through every aspect of our business and the people we serve, starting with discovering the best treatments for those who take our medicines and extending to health care professionals, employees and the communities in which we live. Moreover, you can also count on the team at Lilly to be incredibly civic-minded, supporting our communities through philanthropy, volunteerism, and a creative and innovative can-do spirit.

Karina found her fit at Lilly through our summer internship program. She is now hoping to inspire more Latinx students to make changes in the STEM field just as her mentor did for her. Visit careers.lilly.com/LRL to find open roles in Lilly’s research labs. #WeAreLilly

893 S Delaware St
Indianapolis, IN 46285

Discovery is
in our DNA

Exceptional people with an
extraordinary purpose.
Our values and commitment
have guided our success
for over 140 years.

Explore Careers

We are Lilly

Why do our employees love coming to work each and every day? Here’s what they have to say.

“Opportunity for growth is actually the biggest reason that I ended up hiring into Lilly.”

Kavita - Associate Director, Packaging Operations
“Lilly worked bery hard to be able to allow me to settle into my role, but they also had a great deal of consideration for my life outside of work.”

Adrian - Associate Director, IDM
“What we do matters, it matters to the people that we interact with. It matters to people in our families and it matters to people around the world.”

Cecile - Sr Director, Design Hub Foundations

39,000 global employees coming together from diverse backgrounds to create medicines that make life better for people around the world. Get to know us through our Powered by Purpose series.

View Stories

NEWS

External view of the U.S. Capitol building at sunset

Drug pricing

Amgen, Lilly Are Part of Ongoing Senate Probe Into Pharma’s Restrictions on 340B Program

A senior senator has asked the CEOs of both companies to provide information about the limits they are putting on 340B drug pricing for hospitals.

September 24, 2024

2 min read

Tristan Manalac

External view of Eli Lilly's world headquarters in Indianapolis

Approvals

Lilly Secures FDA Nod for Eczema Therapy, Eyes Launch in ‘Coming Weeks’

Friday’s approval comes after a previous rejection in October 2023 due to manufacturing concerns.

September 16, 2024

2 min read

Tristan Manalac

Pictured: Eli Lilly's biotechnology center in San Diego, California

Diabetes

Lilly Continues Once-Weekly Insulin Rally With Two Phase III Diabetes Readouts

The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for patients with type 1 and 2 diabetes, respectively.

September 11, 2024

2 min read

Tristan Manalac

Weight loss

Terns Shares Climb as Investigational GLP-1 Pill Spurs 5% Weight Loss After 28 Days

Terns Pharmaceuticals will advance TERN-601 into Phase II after early-stage data showed the oral therapy led to weight loss of 4.9%, comparable with weight loss pills Lilly and Pfizer are developing, according to analysts.

September 9, 2024

1 min read

Annalee Armstrong

Eli Lilly's world headquarters in Indianapolis

Diabetes

Lilly Gains Ground on Novo With Positive Phase III Readouts for Weekly Insulin

Eli Lilly’s weekly insulin injection efsitora alfa secured two late-stage victories on Thursday in a potential blow to rival Novo Nordisk, which in July failed to secure the FDA’s approval for its basal insulin icodec.

September 5, 2024

2 min read

Tristan Manalac

Deals

Lilly, Haya Ink Potential $1B Drug Discovery Deal to Target Obesity and Metabolic Conditions

Under a multi-year agreement announced Wednesday, Eli Lilly will leverage Haya Therapeutics’ proprietary RNA-guided genome platform to identify drug targets to address the chronic conditions.

September 4, 2024

2 min read

Kate Goodwin

Medical characters fighting the epidemic flat vector concept operation hand drawn illustration

Business

Lilly, Pfizer Take Meds Straight To Consumers in Renewed DTC Push

Big Pharma has finally gotten its arms around something advocates have wanted for a long time: direct-to-consumer sales. Eli Lilly and Pfizer are leading the way.

September 4, 2024

5 min read

Annalee Armstrong

Podcast

Lilly’s DTC Obesity Push, Layoffs, and an Eye on Ocular Diseases

Eli Lilly offers weight loss drug Zepbound directly to consumers while Novo Nordisk continues to struggle with supply challenges for its own GLP-1s. Meanwhile, gene therapies for retinal diseases target competitive market, and layoffs persist.

September 4, 2024

1 min read

Heather McKenzie

U.S. Capitol surrounded by money and pill bottles/Taylor Tieden for BioSpace

Editorial

With Lilly’s Zepbound Price Cut and Novo’s Impending Senate Hearing, Wegovy Is in the Hot Seat

Eli Lilly this week announced plans to sell single-dose vials of its weight loss drug Zepbound directly to consumers. Novo Nordisk could adopt a similar strategy for Wegovy as its CEO is set to testify Sept. 24 before the Senate health committee.

August 30, 2024

3 min read

Greg Slabodkin

JOBS